RNS Number : 8110M
Seraphim Space Investment Trust PLC
19 September 2023
SERAPHIM SPACE INVESTMENT TRUST PLC
("Seraphim Space" or "the Company")
Notice of Results
Seraphim Space Investment Trust plc (LSE: SSIT), the world's first SpaceTech investment company, will announce its audited results for the financial year ended 30 June 2023 (the "Results") on Tuesday, 17 October 2023. The Company therefore entered into a closed period on 17 September 2023 which will last until the Results are published.
There will be a webinar for equity analysts at 09.00 (UK time) on the day of results. To register for the event, please contact SEC Newgate by email at seraphim@secnewgate.co.uk.
A further presentation for retail investors will be provided at 11.00 (UK time) on the same day. Investors can register for the event by emailing seraphim@secnewgate.co.uk.
Both presentations will be hosted by the Chair, Will Whitehorn, and Seraphim Space Manager LLP's CEO Mark Boggett and CIO James Bruegger.
- Ends -
Media Enquiries
Seraphim Space Manager LLP (via SEC Newgate)
Mark Boggett, CEO / James Bruegger, CIO / Rob Desborough
SEC Newgate (Communications advisers) seraphim@secnewgate.co.uk
Emma Kane / Clotilde Gros / George Esmond +44 (0) 20 3757 6767
Deutsche Bank
Mark Hankinson / Gavin Deane / Neil Coleman +44 (0) 20 754 58000
J.P. Morgan Cazenove
William Simmonds / Jérémie Birnbaum / Rupert Budge +44 (0) 20 7742 4000
Ocorian Administration (UK) Limited seraphimteam@ocorian.com
Lorna Zimny +44 28 9693 0222
Notes to Editors:
About Seraphim Space Investment Trust
Seraphim Space Investment Trust plc (the "Company" or "SSIT) is the world's first listed fund focused on SpaceTech. The Company seeks exposure predominantly to early and growth stage private financed SpaceTech businesses that have the potential to dominate globally and that are sector leaders with first mover advantages in areas such as climate, communications, mobility and cyber security.
The Company is listed on the Premium Segment of the London Stock Exchange. Further information is available at: https://investors.seraphim.vc
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.